More Post from the Author
- STRADVISION Submits Preliminary Application for KOSDAQ Listing
- Motiva - Results for the 3rd quarter of 2025
- STRADVISION Joins SOAFEE Special Interest Group to Drive Software-Defined Vehicle Innovation
- Energy Demands Fuel Global Nuclear Revival, With 262 Small Modular Reactors to Be Deployed by 2040
- Taxbit Appoints Former OECD Advisor Colby Mangels as Global Head of Government Solutions
Informatics Illuminated: Science Bytes Podcast Explores the Power Behind Smarter Diagnostics
 
                SAN DIEGO, Oct. 23, 2025 /PRNewswire/ -- QuidelOrtho Corporation (Nasdaq: QDEL), a global leader in in vitro diagnostics, has released Episode 52 of its Science Bytes podcast, featuring George Wierschem, MBA, MT(ASCP), Senior Global Product Manager - Informatics.
In the episode titled "The Power of Informatics in Clinical Decision-Making," Wierschem shares how informatics platforms are transforming laboratory operations by connecting instruments, data systems and clinical decisions. Drawing on over 30 years of laboratory experience, he explains howinformatics has evolved from a helpful tool to a critical engine driving lab efficiency, data integrity and patient care.
Key insights include:
- Insight in an instant: Informatics turns data into decisions
- Smarter workflows: Automation speeds up results and reduces error
- Point-of-care confidence: Ensures quality across decentralized testing
- Built-in security: Cyber-safe systems that don't slow you down
- Trustworthy data: Tracks every step for full accountability
This episode underscores howinformatics is helping labs stay agile, secure and future-ready - especially as demands for speed and accuracy continue to grow.
The QuidelOrtho Science Bytes podcast is available on major streaming platforms and at: https://www.quidelortho.com/global/en/resources/podcasts/quidelortho-science-bytes.
About QuidelOrtho Corporation
With expertise spanning clinical chemistry, immunoassay, immunohematology and molecular testing, QuidelOrtho Corporation (Nasdaq: QDEL) is a leading global provider of diagnostic solutions, delivering fast, accurate and reliable results that help improve patient outcomes - from the point of care to lab, clinic to hospital. Building on a legacy of innovation, QuidelOrtho works with healthcare providers to advance diagnostics that connect insights with solutions, defining a clearer path for informed decisions and better care.
 Investor Contact:
Juliet Cunningham
Vice President, Investor Relations
[emailprotected]
 Media Contact:
D. Nikki Wheeler
Senior Director, Corporate Communications
[emailprotected]
SOURCE QuidelOrtho Corporation

More Post from the Author
- STRADVISION Submits Preliminary Application for KOSDAQ Listing
- Motiva - Results for the 3rd quarter of 2025
- STRADVISION Joins SOAFEE Special Interest Group to Drive Software-Defined Vehicle Innovation
- Energy Demands Fuel Global Nuclear Revival, With 262 Small Modular Reactors to Be Deployed by 2040
- Taxbit Appoints Former OECD Advisor Colby Mangels as Global Head of Government Solutions


